{
    "clinical_study": {
        "@rank": "144690", 
        "arm_group": {
            "arm_group_label": "Desflurane increment", 
            "arm_group_type": "Experimental", 
            "description": "increment of desflurane 0.5-1.5 MAC in remifentanil anesthesia for cardiac surgery"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine desflurane's dose-dependent effect on left\n      ventricular (LV) function in cardiac surgery. The change of tissue Doppler imaging (TDI) of\n      lateral mitral valve annular velocity at three different desflurane concentrations would be\n      analyzed by using intraoperative transesophageal echocardiography (TEE) in cardiac surgery\n      patients"
        }, 
        "brief_title": "Effect of Desflurane on Cardiac Function During Cardiac Surgery: Tissue Doppler Imaging of Mitral Valve Annular Velocity", 
        "completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Valvular Heart Disease", 
        "condition_browse": {
            "mesh_term": [
                "Heart Diseases", 
                "Heart Valve Diseases"
            ]
        }, 
        "detailed_description": {
            "textblock": "Tissue Doppler imaging (TDI ) of mitral annular velocity during the cardiac cycle has been\n      introduced as a reliable method for analysis of systolic and diastolic LV ling-axix function\n      , efficacy of diastolic TDI profile, including early early relaxation (E') and atrial\n      contraction (A') and has been suggested to be useful in predicting the postoperative\n      clinical outcomes and the impact of isoflurane on LV diastolic function.\n\n      Desflurane is widely used in cardiac surgery patients due to its beneficial effects , but\n      many studies have shown that desflurane reduces myocardial contractility in a dose-dependent\n      manner, and compromises left ventricular( LV) function We hypothesized that desflurane ,\n      even at a clinical dosage, would affects intraoperative LV systolic function in a\n      dose-dependent manner and thus produce significant changes int the TDI profiles of mitral\n      annular velocity.\n\n      So we planned to study the changes in TDI profiles of lateral mitral annular velocity at the\n      clinical desflurane dosage during remifentanil based anesthesia for cardiac surgery"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Ages eligible for study : 20 years to 65 years Genders eligible for study : Both\n\n        Inclusion Criteria:\n\n          -  Patients undergoing cardiac surgery\n\n        Exclusion Criteria:\n\n          -  Low ejection fraction <50% in preoperative transthoracic echocardiography\n\n          -  Atrial fibrillation\n\n          -  Pacemaker\n\n          -  Pericardial and infiltrative myocardial disease\n\n          -  Mitral annular calcification, surgical rings, prosthetic mitral valves\n\n          -  Lateral left ventricular regional wall motion abnormality\n\n          -  Esophageal spasm, stricture, laceration, perforation, and diverticulum\n\n          -  Diaphragmatic hernia\n\n          -  History of extensive radiation to mediastinum\n\n          -  Upper gastrointestinal bleeding"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "65 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "14", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 28, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02003885", 
            "org_study_id": "20130523"
        }, 
        "intervention": {
            "arm_group_label": "Desflurane increment", 
            "description": "After achieving stable hemodynamics and BIS 40-60 with desflurnae 0.5 MAC and remifentanil 0.7-1.0 mcg/kg/min (T1), data including S', E', A', EF, E, A and BIS are determined.\nAfter 10 min exposure to the increased desflurane dosage 1.0 MAC (T2), data are determiend. After 10 min exposure to the increased desflurane dosage 1.5 MAC (T3), data are determined.\nReduction of BP is managed by the increment of phenylephrine infusion", 
            "intervention_name": "increment of desflurane", 
            "intervention_type": "Drug", 
            "other_name": "Desflurane inhalation 0.5 MAC, 1.0 MAC and 1.5 MAC"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Desflurane", 
                "Isoflurane", 
                "Remifentanil"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": "Desflurane, mitral annular velocity, tissue Doppler imaging", 
        "lastchanged_date": "December 5, 2013", 
        "location": {
            "contact": {
                "email": "20110360@kuh.ac.kr", 
                "last_name": "Seong-Ho Lee", 
                "phone": "82-2-2030-6522"
            }, 
            "facility": {
                "address": {
                    "city": "Seoul", 
                    "country": "Korea, Republic of", 
                    "zip": "143729"
                }, 
                "name": "Konkuk University Medical Center"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "1", 
        "official_title": "Effect of Desflurane on Left Ventricular Function in Remifentanil-based Anesthesia for Cardiac Surgery: Tissue Doppler Imaging of Mitral Valve Annular Velocity", 
        "overall_contact": {
            "last_name": "Tae-Yop Kim, MD, PhD", 
            "phone": "82-10-8811-6942"
        }, 
        "overall_official": {
            "affiliation": "Konkuk University Medical Center", 
            "last_name": "Tae-Yop Kim, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Peak systolic mitral annular velocity (S') using tissue Doppler imaging By using pulsed Doppler with the sample volume positioned at the lateral mitral valve (MV)ring in the midesophageal 4-chamber view, S' would be determined just after the 10 min-exposure to each concentration of desflurane, 0.5 MAC, 1.0 MAC and 1.5 MAC (T1, T2 and T3, respectively)", 
            "measure": "Peak systolic mitral annular velocity (S')", 
            "safety_issue": "No", 
            "time_frame": "after 10 min exposure to desflurane 0.5, 1.0 and 1.5 MAC"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02003885"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Konkuk University Medical Center", 
            "investigator_full_name": "Tae-Yop Kim, MD PhD", 
            "investigator_title": "Professor of Anesthesiology", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Peak mitral annular velocity during early diastole (E'): By using pulsed Doppler with the sample volume positioned at the lateral MV ring in the midesophageal 4-chamber view, Peak mitral annular velocity during atrial contraction(A'): By using pulsed Doppler with the sample volume positioned at the lateral MV ring in the midesophageal 4-chamber view, ejection fraction (EF): By using modified Simpson technique in the midesophageal 4-chamber view, bispectral index (BIS) peak velocity of mitral inflow during early relaxation (E): By using pulsed Doppler with the sample volume positioned at the IMV opening in the midesophageal 4-chamber view, peak velocity of mitral inflow during atrial contraction (A): By using pulsed Doppler with the sample volume positioned at the tip of MV opening in the midesophageal 4-chamber view,", 
            "measure": "diastolic mital annular veocities (E' and A'), ejection fraction (EF), Bispectral index", 
            "safety_issue": "No", 
            "time_frame": "after 10 min exposure to desflurane 0.5, 1.0 and1.5 MAC"
        }, 
        "source": "Konkuk University Medical Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Konkuk University Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}